Cargando…

Real-world effectiveness of app-based treatment for urinary incontinence: a cohort study

OBJECTIVES: The efficacy of app-based treatment for stress urinary incontinence (SUI) has been demonstrated in a randomised controlled trial (RCT). In this study, we investigate the user characteristics and the effectiveness of the same app when freely available, and compare these results with the R...

Descripción completa

Detalles Bibliográficos
Autores principales: Rygh, Pontus, Asklund, Ina, Samuelsson, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783523/
https://www.ncbi.nlm.nih.gov/pubmed/33397664
http://dx.doi.org/10.1136/bmjopen-2020-040819
_version_ 1783632134051725312
author Rygh, Pontus
Asklund, Ina
Samuelsson, Eva
author_facet Rygh, Pontus
Asklund, Ina
Samuelsson, Eva
author_sort Rygh, Pontus
collection PubMed
description OBJECTIVES: The efficacy of app-based treatment for stress urinary incontinence (SUI) has been demonstrated in a randomised controlled trial (RCT). In this study, we investigate the user characteristics and the effectiveness of the same app when freely available, and compare these results with the RCT. DESIGN: Prospective cohort study. PARTICIPANTS: During a 17-month period, 24 602 non-pregnant, non-postpartum women older than 18 years downloaded the app and responded anonymously to a questionnaire. Of these, 2672 (11%) responded to the 3-month follow-up. INTERVENTION: Three months’ use of the app Tät, containing information, a pelvic floor muscle training programme and lifestyle advice. MAIN OUTCOME MEASURES: Change in symptom severity (International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF)) and subjective improvement (Patient Global Impression of Improvement (PGI-I)). RESULTS: Of the respondents, 88% lived in Sweden and 75% (18 384/24 602) were incontinent with a mean age of 45.5 (SD 14.1) years. The UI types, based on symptoms, were SUI (53%), urgency UI (12%), mixed UI (31%) and undefined (4%). The mean ICIQ-UI SF score was 8.2 (SD 4.0) at baseline. The mean ICIQ-UI SF score reduction at follow-up was 1.31 (95% CI: 1.19 to 1.44) with a larger reduction in those with more severe incontinence at baseline (severe/very severe 3.23 (95% CI: 2.85 to 3.61), moderate 1.41 (95% CI: 1.24 to 1.59) and slight 0.24 (95% CI 0.06 to 0.42). When the results were weighted to match the distribution of severity in the RCT, the ICIQ-UI SF score reduction was 2.2 compared with 3.9 in the RCT. Regarding PGI-I, 65% experienced improvement compared with 92% in the RCT. CONCLUSIONS: The app Tät was effective for self-management of UI even in the real world. Although the reduction in incontinence symptoms was less than in the RCT, two-thirds of the users improved. App-based treatment reaches many women without requiring resources from ordinary healthcare services.
format Online
Article
Text
id pubmed-7783523
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-77835232021-01-11 Real-world effectiveness of app-based treatment for urinary incontinence: a cohort study Rygh, Pontus Asklund, Ina Samuelsson, Eva BMJ Open Urology OBJECTIVES: The efficacy of app-based treatment for stress urinary incontinence (SUI) has been demonstrated in a randomised controlled trial (RCT). In this study, we investigate the user characteristics and the effectiveness of the same app when freely available, and compare these results with the RCT. DESIGN: Prospective cohort study. PARTICIPANTS: During a 17-month period, 24 602 non-pregnant, non-postpartum women older than 18 years downloaded the app and responded anonymously to a questionnaire. Of these, 2672 (11%) responded to the 3-month follow-up. INTERVENTION: Three months’ use of the app Tät, containing information, a pelvic floor muscle training programme and lifestyle advice. MAIN OUTCOME MEASURES: Change in symptom severity (International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF)) and subjective improvement (Patient Global Impression of Improvement (PGI-I)). RESULTS: Of the respondents, 88% lived in Sweden and 75% (18 384/24 602) were incontinent with a mean age of 45.5 (SD 14.1) years. The UI types, based on symptoms, were SUI (53%), urgency UI (12%), mixed UI (31%) and undefined (4%). The mean ICIQ-UI SF score was 8.2 (SD 4.0) at baseline. The mean ICIQ-UI SF score reduction at follow-up was 1.31 (95% CI: 1.19 to 1.44) with a larger reduction in those with more severe incontinence at baseline (severe/very severe 3.23 (95% CI: 2.85 to 3.61), moderate 1.41 (95% CI: 1.24 to 1.59) and slight 0.24 (95% CI 0.06 to 0.42). When the results were weighted to match the distribution of severity in the RCT, the ICIQ-UI SF score reduction was 2.2 compared with 3.9 in the RCT. Regarding PGI-I, 65% experienced improvement compared with 92% in the RCT. CONCLUSIONS: The app Tät was effective for self-management of UI even in the real world. Although the reduction in incontinence symptoms was less than in the RCT, two-thirds of the users improved. App-based treatment reaches many women without requiring resources from ordinary healthcare services. BMJ Publishing Group 2021-01-04 /pmc/articles/PMC7783523/ /pubmed/33397664 http://dx.doi.org/10.1136/bmjopen-2020-040819 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Urology
Rygh, Pontus
Asklund, Ina
Samuelsson, Eva
Real-world effectiveness of app-based treatment for urinary incontinence: a cohort study
title Real-world effectiveness of app-based treatment for urinary incontinence: a cohort study
title_full Real-world effectiveness of app-based treatment for urinary incontinence: a cohort study
title_fullStr Real-world effectiveness of app-based treatment for urinary incontinence: a cohort study
title_full_unstemmed Real-world effectiveness of app-based treatment for urinary incontinence: a cohort study
title_short Real-world effectiveness of app-based treatment for urinary incontinence: a cohort study
title_sort real-world effectiveness of app-based treatment for urinary incontinence: a cohort study
topic Urology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783523/
https://www.ncbi.nlm.nih.gov/pubmed/33397664
http://dx.doi.org/10.1136/bmjopen-2020-040819
work_keys_str_mv AT ryghpontus realworldeffectivenessofappbasedtreatmentforurinaryincontinenceacohortstudy
AT asklundina realworldeffectivenessofappbasedtreatmentforurinaryincontinenceacohortstudy
AT samuelssoneva realworldeffectivenessofappbasedtreatmentforurinaryincontinenceacohortstudy